Deep Brain Stimulation Systems Global Market Report 2024

The deep brain stimulation systems market size has grown rapidly in recent years. It will grow from $2.28 billion in 2023 to $2.53 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth observed during the historic period can be attributed to several factors, including the rising preference for less invasive operations among the general public, an increasing demand for minimally invasive surgery in developed countries, a growing need for minimally invasive surgical procedures, a high prevalence of diseases such as Parkinson's disease and epilepsy, and an overall increasing prevalence of neurological disorders.

The deep brain stimulation systems market size is expected to see rapid growth in the next few years. It will grow to $3.76 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period can be attributed to factors such as the increasing growth in the geriatric population, a rising prevalence of neurological disorders globally, the expanding aging population, growing acceptance of neurostimulation therapies, and an increasing focus on healthcare infrastructure development. Major trends expected in the forecast period include technological advancements in deep brain stimulation devices, continuous progress in technology, an increased focus on addressing non-motor symptoms, advancements in miniaturization and the use of advanced materials, the incorporation of wireless connectivity and remote monitoring, and the adoption of multimodal therapies.

The escalating prevalence of neurological disorders is poised to propel growth within the deep brain stimulation systems market in the foreseeable future. Neurological disorders encompass a spectrum of heterogeneous diseases impacting the autonomic, peripheral, and central nervous systems. Deep brain stimulation systems play a pivotal role in neurosurgical interventions by delivering electrical stimulation to targeted brain regions, with the aim of modulating neural activity and achieving therapeutic outcomes that are reversible, adjustable, and beneficial. As exemplified by data from the Parkinson's Foundation in March 2023, nearly 90,000 individuals are diagnosed with Parkinson's disease (PD) annually in the US, representing a significant 50% increase from previous estimates. Moreover, according to the Centers for Disease Control and Prevention in October 2022, the number of Americans affected by Alzheimer's disease is projected to nearly triple from 5.8 million in 2020 to 14 million by 2060. Consequently, the mounting incidence of neurological disorders drives the expansion of the deep brain stimulation systems market.

Key players within the deep brain stimulation systems market are actively engaged in pioneering innovative technologies, such as deep brain stimulation (DBS) systems, to cater to patients with movement disorders. DBS entails a medical procedure involving the implantation of a device that administers electrical currents directly to specific brain regions. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and healthcare company, unveiled the Liberta RC DBS system - a groundbreaking rechargeable deep brain stimulation device with remote programming capabilities, deemed the world's smallest in its category. The Liberta RC DBS system represents a pioneering advancement in connected care technology, allowing patients to maintain communication with their healthcare providers, ensure optimal device configuration and operation, and receive updated treatment settings remotely as needed, eliminating the necessity for in-person visits to medical facilities.

In August 2022, Aster Medcity, a leading quaternary care multispecialty hospital based in India, established a partnership with Medtronic plc. This collaboration seeks to expand the outreach of the program to encompass all Parkinson's patients, with a particular focus on individuals with early-onset or young-onset Parkinson's. Additionally, the partnership aims to develop a comprehensive and advanced Deep Brain Stimulation (DBS) program dedicated to treating Parkinson's disease and other movement disorders. Medtronic plc., an India-based medical device company, brings to the partnership its expertise in offering a complete range of deep brain stimulation technology, technical support, and experience.

Major companies operating in the deep brain stimulation systems market report are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Quest Diagnostics Inc., St. Jude Medical Inc., Stanford Health Care, Associated Regional and University Pathologists Inc., LivaNova PLC, OPKO Health Inc., Nordic Laboratories, Myriad Genetics Inc., Nevro Corporation, Genomic Health, Mayo Medical Laboratories, Foundation Medicine Inc., SceneRay Co., ACM Global Laboratories, Neuropace Inc., American Esoteric Laboratories, Nexstim Oy, Aleva Neurotherapeutics S.A., NeuroSigma Inc., Beijing PINS Medical Co. Ltd., BioMONTR Labs, Functional Neuromodulation Ltd., Miraca Holdings Inc., Nuvectra Corporation.

North America was the largest region in the deep brain stimulation systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the deep brain stimulation systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A deep brain stimulation (DBS) system is a medical device that employs implanted electrodes to deliver controlled electrical pulses to specific areas of the brain. This technology is utilized to regulate abnormal brain activity and alleviate symptoms associated with various neurological conditions.

The primary products within the realm of deep brain stimulation systems are single-channel and dual-channel systems. Single-channel systems involve devices designed for applying targeted electrical or magnetic stimulation to specific brain regions. These systems find applications across various medical conditions, including Parkinson's disease, essential tremor, obsessive-compulsive disorder, epilepsy, dystonia, and others. These systems are employed by diverse end-users such as hospitals, ambulatory surgical centers, neurological clinics, and other healthcare facilities.

The deep brain stimulation systems market research report is one of a series of new reports that provides deep brain stimulation systems market statistics, including deep brain stimulation systems industry global market size, regional shares, competitors with an deep brain stimulation systems market share, detailed deep brain stimulation systems market segments, market trends and opportunities, and any further data you may need to thrive in the deep brain stimulation systems industry. This deep brain stimulation systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The deep brain stimulation system market includes revenues earned by entities by providing services such as electrode implantation, pulse generator implantation, surgical implantation services, diagnostic and preoperative services, programming and adjustment services, patient education and support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The deep brain stimulation system market also includes of sales of extension wires, remote controls, and electrodes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.